Privia Health Group (NASDAQ:PRVA) Price Target Raised to $24.00 at Barclays

Privia Health Group (NASDAQ:PRVA - Get Free Report) had its target price hoisted by stock analysts at Barclays from $23.00 to $24.00 in a report released on Tuesday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Barclays's price objective indicates a potential upside of 4.99% from the company's previous close.

A number of other brokerages also recently issued reports on PRVA. Piper Sandler increased their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. Truist Financial raised their target price on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. JMP Securities restated a "market outperform" rating and issued a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th. Canaccord Genuity Group raised their target price on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Finally, Needham & Company LLC restated a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $27.77.

Privia Health Group Price Performance

PRVA stock traded up $0.31 during mid-day trading on Tuesday, reaching $22.86. 1,260,625 shares of the company's stock were exchanged, compared to its average volume of 739,124. The company has a market cap of $2.79 billion, a price-to-earnings ratio of 228.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. The stock's 50 day moving average is $23.34 and its 200 day moving average is $22.72. Privia Health Group has a 12-month low of $16.37 and a 12-month high of $26.09.

Insider Activity at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This trade represents a 3.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Parth Mehrotra sold 15,100 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the sale, the chief executive officer now directly owns 454,281 shares of the company's stock, valued at approximately $10,598,375.73. This represents a 3.22% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,579 shares of company stock valued at $1,226,367. 10.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Privia Health Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. US Bancorp DE increased its stake in Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after acquiring an additional 429 shares during the last quarter. Quadrant Capital Group LLC increased its stake in Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after acquiring an additional 511 shares during the last quarter. Park Avenue Securities LLC increased its stake in Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock worth $342,000 after acquiring an additional 532 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock worth $140,000 after acquiring an additional 533 shares during the last quarter. Finally, CWM LLC increased its stake in Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.